Point mutations of the human parathyroid calcium receptor gene are not responsible for non-suppressible renal hyperparathyroidism
- PMID: 9507199
- DOI: 10.1046/j.1523-1755.1998.00802.x
Point mutations of the human parathyroid calcium receptor gene are not responsible for non-suppressible renal hyperparathyroidism
Abstract
The calcium-dependent secretion of parathyroid hormone (PTH) is mediated through an extracellular G protein-coupled calcium receptor (CaR). Inactivating point mutations of this receptor have been found in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. These diseases feature a decreased calcium sensitivity of the parathyroid glands, resulting in a rightward shift of the Ca2(+)-PTH relationship. Severe non-suppressible renal hyperparathyroidism (rHPT) is often characterized by similar setpoint shifts to the right. Thus, point mutations of the CaR gene could contribute to non-suppressible rHPT. We examined genomic DNA of hyperplastic or mainly nodular tissues of 39 parathyroids from 25 rHPT-patients with resistance to calcitriol therapy. Amplification of the six exons of the CaR gene was followed by single-strand conformation polymorphism (SSCP) analysis. DNA sequencing was performed where band shifts were observed. No point mutations in the coding sequence of the CaR gene were detected using the PCR-SSCP strategy. Point mutations in the coding regions of the CaR gene probably play no role in the evolution of renal HPT and are not responsible for the calcitriol resistance of PTH secretion.
Similar articles
-
Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism.J Clin Invest. 1995 Dec;96(6):2683-92. doi: 10.1172/JCI118335. J Clin Invest. 1995. PMID: 8675635 Free PMC article.
-
Heterogeneous expression of receptor mRNAs in parathyroid glands of secondary hyperparathyroidism.Kidney Int. 2001 Nov;60(5):1666-75. doi: 10.1046/j.1523-1755.2001.00986.x. Kidney Int. 2001. PMID: 11703583
-
In vivo and in vitro characterization of neonatal hyperparathyroidism resulting from a de novo, heterozygous mutation in the Ca2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia.J Clin Invest. 1997 Jan 1;99(1):88-96. doi: 10.1172/JCI119137. J Clin Invest. 1997. PMID: 9011580 Free PMC article.
-
Activating mutations of the Ca2+-sensing receptor.Mol Genet Metab. 1998 Jul;64(3):198-204. doi: 10.1006/mgme.1998.2716. Mol Genet Metab. 1998. PMID: 9719629 Review.
-
The First Annual Bayard D. Catherwood Memorial Lecture. Ca2+-receptor-mediated regulation of parathyroid and renal function.Am J Med Sci. 1996 Sep;312(3):99-109. Am J Med Sci. 1996. PMID: 8783675 Review.
Cited by
-
Molecular genetics of parathyroid disease.World J Surg. 2009 Nov;33(11):2224-33. doi: 10.1007/s00268-009-0022-6. World J Surg. 2009. PMID: 19373510 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous